Literature DB >> 15311348

Early age of onset in fatal familial insomnia. Two novel cases and review of the literature.

A Harder1, A Gregor, T Wirth, F Kreuz, W J Schulz-Schaeffer, O Windl, M Plotkin, H Amthauer, K Neukirch, H A Kretzschmar, T Kuhlmann, R Braas, H H Hahne, K Jendroska.   

Abstract

Fatal familial insomnia (FFI) is a prion disease exhibiting the PRNP D178N/129M genotype. Features of this autosomal dominant illness are progressive insomnia, dysautonomia, myoclonus, cognitive decline and motor signs associated with thalamic nerve cell loss and gliosis. In contrast to the new variant of Creutzfeldt-Jakob disease (vCJD) the onset of FFI is in middle to late adulthood. We report two male patients who belong to a large German FFI kindred. They were examined clinically, and postmortem neuropathological examination was carried out in collaboration with the German reference centre for prion disease. Additionally, the prion protein gene (PRNP) was analysed. To identify further patients with disease onset under 30 years of age a comprehensive literature review was carried out. Two male patients presented with typical symptoms of FFI at the age of 23 and 24 years. In their kindred, the age of onset has never before been under 44 years of age. Our literature review identified five additional early onset cases who died at age 21 to 25 years. In all 22 reviewed FFI families the median manifestation age was 49.5 years. Although phenotypic variability of FFI is common, age of onset under 30 years has been considered to be a hallmark of vCJD with a mean manifestation at 27 years of age. Our findings underline that in addition to vCJD, FFI must be considered in cases of young-onset prion disease. This has considerable impact on clinical management and genetic counselling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15311348     DOI: 10.1007/s00415-004-0409-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

1.  Early onset fatal familial insomnia with rapid progression in a Chinese family line.

Authors:  Shuiliang Yu; Yunjian Zhang; Shu Li; Man-Sun Sy; Shenggang Sun; Po Tien; Gengfu Xiao
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849

Review 2.  Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations.

Authors:  Franc Llorens; Juan-José Zarranz; Andre Fischer; Inga Zerr; Isidro Ferrer
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

3.  Clinical, histopathological and genetic studies in a case of fatal familial insomnia with review of the literature.

Authors:  Bin Peng; Shenqi Zhang; Hongjuan Dong; Zuneng Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Does the clinical phenotype of fatal familial insomnia depend on PRNP codon 129 methionine-valine polymorphism?

Authors:  Sven Rupprecht; Alexander Grimm; Torsten Schultze; Jan Zinke; Panagiota Karvouniari; Hubertus Axer; Otto W Witte; Matthias Schwab
Journal:  J Clin Sleep Med       Date:  2013-12-15       Impact factor: 4.062

5.  Sleep Pathology in Creutzfeldt-Jakob Disease.

Authors:  Peter Kang; Gabriela S de Bruin; Leo H Wang; Beth A Ward; Beau M Ances; Miranda M Lim; Robert C Bucelli
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

6.  Expert Consensus on Clinical Diagnostic Criteria for Fatal Familial Insomnia.

Authors:  Li-Yong Wu; Shu-Qin Zhan; Zhao-Yang Huang; Bin Zhang; Tao Wang; Chun-Feng Liu; Hui Lu; Xiao-Ping Dong; Zhi-Ying Wu; Jie-Wen Zhang; Ji-Hui Zhang; Zhong-Xin Zhao; Fang Han; Yan Huang; Jun Lu; Serge Gauthier; Jian-Ping Jia; Yu-Ping Wang
Journal:  Chin Med J (Engl)       Date:  2018-07-05       Impact factor: 2.628

Review 7.  Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases.

Authors:  Eva Bagyinszky; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-14       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.